3D Systems Corporation (DDD) SEC Filings & Earnings Calls
EquiReason read 16 3D Systems Corporation SEC filings in the last 12 months. Latest: 8-K on 2026-08-04 — Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update).
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 505.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
4 Aug 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Leadership transition risk due to CEO departure
“CEO leaving; successor not yet identified; severance agreement with 150% base salary.”
3 Aug 20268-K · 2.02Revenue $95M (-0% y/y); Gross Profit $34M (-5% y/y); Gross Profit Margin 36.4earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $95M | -0% y/y |
| Gross Profit · Q2-2026 | $35M | -5% y/y |
| Gross Profit Margin · Q2-2026 | 36.4% | |
| Net Loss Attributable to 3D Systems · Q2-2026 | $-13M | |
| Adjusted EBITDA · Q2-2026 | $-800000.00 | |
| Healthcare Solutions Revenue · Healthcare · Q2-2026 | $48M | +7% y/y |
| Industrial Solutions Revenue · Industrial · Q2-2026 | $47M | -7% y/y |
| Cash and Cash Equivalents · Q2-2026 | $128M | |
| Diluted Loss Per Share · Q2-2026 | $-0.09 |
Risks flagged
Revenue still declining YoY; industrial segment weak.
“Total revenue decreased 0.3% to $94.6 million; Industrial Solutions revenue decreased 6.7%.” · word for word
Gross margin pressure from product mix and pricing.
“Gross profit margin decreased to 36.4% compared to 38.1%.” · word for word
Net loss continues; reliance on cost reduction for profitability.
“Net loss of $(12.9) million; Adjusted EBITDA still negative.”
Equity dilution from share issuance.
“Issued 18.9 million shares for $53.2 million.”
3 Aug 202610-Q3D Systems reported Q2 2026 revenue nearly flat YoY, with Healthcare growth offset by Industrial decline, and gross margin contracting 170bps.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $95M | -0% y/y |
| Revenue · H1-2026 | $190M | +0% y/y |
| Gross Profit Margin · Q2-2026 | 36.4% | |
| Cash and Cash Equivalents · 2026-06-30 | $128M |
Risks flagged
Macroeconomic challenges impacting financial performance
“In 2025, in response to continuing macroeconomic challenges impacting the Company’s financial performance, the Company implemented a series of cost savings and restructuring initiatives.” · word for word
Supply chain and component shortages
“Our dependence on our supply chain for components and sub-assemblies used in our 3D printers and other products and for raw materials used in our print materials.” · word for word
Concentration of revenue from largest customer
“The concentration of revenue and credit risk exposure from our largest customer.” · word for word
5 Jun 20268-K · 1.013D Systems entered an underwriting agreement to sell 16,393,443 shares at $3.05/share, raising ~$50M gross proceeds. The offering dilutes existing shareholders.open
Figures in the filing · each found in the filing text
| Shares offered · Q2-2026 | 16,393,443 | |
| Offering price per share · Q2-2026 | $3.05 | |
| Gross proceeds · Q2-2026 | $50M | |
| Over-allotment option shares · Q2-2026 | 2,459,016 |
Risks flagged
Dilution risk from equity offering
“16.4M new shares issued at $3.05; potential additional 2.46M shares from over-allotment.”
15 May 20268-K · 5.02, 5.03, 5.07Authorized shares increase 220,000,000; new incentive plan shares 4,000,000open
Figures in the filing · each found in the filing text
| authorized shares increase · Q2-2026 | 220,000,000 | |
| new incentive plan shares · Q2-2026 | 4,000,000 |
Risks flagged
Potential dilution of ~50% from authorized share increase; may signal future equity issuance.
“Authorized shares doubled from 220M to 440M; 4M shares added to incentive plan.”
11 May 202610-QRevenue $96M (+1% y/y); Gross profit margin 35.9; Cash and cash equivalents $85Mopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $96M | +1% y/y |
| Gross profit margin · Q1-2026 | 35.9% | |
| Cash and cash equivalents · 2026-03-31 | $85M | |
| Loss from operations · Q1-2026 | $-7M | |
| Product revenue · Q1-2026 | $58M | +6% y/y |
Risks flagged
Divestiture Impact on Revenue
“Service revenue decreased $2.0 million due to the impact of the divestitures” · word for word
Interest Expense Increase
“Interest expense increased by $1.6 million for the three months ended March 31, 2026, compared to the prior year period, primarily due to interest expense related to the 2030 Notes.” · word for word
Cash Burn
“Cash and cash equivalents totaled $85.1 million and decreased $10.6 million since December 31, 2025. This decrease resulted primarily from cash used in operations of $7.2 million and capital expenditures of $2.1 million.” · word for word
11 May 20268-K · 2.02Revenue $96M (+1% y/y); Healthcare Solutions revenue $50M (+21% y/y); Industrial Solutions revenue $45M (-15% y/y); Guidance: Q2 2026 revenue $93-95M; Adjusted EBITDA ($4M)-($2M)earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $96M | +1% y/y |
| Healthcare Solutions revenue · Healthcare Solutions · Q1-2026 | $50M | +21% y/y |
| Industrial Solutions revenue · Industrial Solutions · Q1-2026 | $45M | -15% y/y |
| Gross profit margin · Q1-2026 | 35.9% | |
| Adjusted EBITDA · Q1-2026 | $2M | |
| Net loss attributable to 3D Systems Corporation · Q1-2026 | $-4M | |
| Diluted loss per share · Q1-2026 | $-0.03 | |
| Cash and cash equivalents · Q1-2026 | $85M |
Guidance
Q2 2026 revenue $93-95M; Adjusted EBITDA ($4M)-($2M)
Q2 2026 guidance: revenue $93-95M (slightly below Q1), Adjusted EBITDA loss of $2-4M, but management optimistic about long-term growth.
Risks flagged
Global economic uncertainty and multi-year downturn in additive manufacturing industry.
“Amid ongoing global risks, the Company remains focused on building top-line momentum in key markets over the coming quarters.” · word for word
Industrial Solutions revenue declined 15% YoY, indicating weakness in that segment.
“Industrial Solutions revenue decreased approximately 15% to $45.4 million compared to the prior year period.” · word for word
8 Apr 2026DEF 14AProxy statement disclosing executive compensation, governance, and shareholder proposals for 2026 annual meeting.open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $387M | |
| Adjusted EBITDA · FY2025 | $-45M | |
| Net Income · FY2025 | $30M | |
| Total Shareholder Return (TSR) · FY2025 | $17.00 | |
| Peer Group TSR · FY2025 | $141.00 |
Risks flagged
Material Weaknesses in Internal Control
“The Company is currently in the process of remediating the remaining portions of these material weaknesses.” · word for word
Significant Underperformance vs Budget
“Our performance under the 2025 Annual Bonus Program fell below threshold for both revenue and adjusted EBITDA.” · word for word
Depressed Stock Price
“Value calculated based on the $1.77 closing price of our stock on December 31, 2025.” · word for word
9 Mar 20268-K · 2.02Revenue $106M (-4% y/y); Revenue $387M (-12% y/y); Gross profit margin 30.8; Guidance: Q4 revenue grew 16% sequentially vs guidance of 8-10%earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q4-2025 | $106M | -4% y/y |
| Revenue · FY2025 | $387M | -12% y/y |
| Gross profit margin · Q4-2025 | 30.8% | |
| Net loss attributable to 3D Systems Corporation · Q4-2025 | $-20M | |
| Net income attributable to 3D Systems Corporation · FY2025 | $30M | |
| Adjusted EBITDA · Q4-2025 | $-5M | |
| Adjusted EBITDA · FY2025 | $-45M | |
| Healthcare Solutions revenue · Healthcare Solutions · Q4-2025 | $51M | +25% y/y |
| Industrial Solutions revenue · Industrial Solutions · Q4-2025 | $56M | -21% y/y |
| Diluted loss per share · Q4-2025 | $-0.15 |
Guidance
Q4 revenue grew 16% sequentially vs guidance of 8-10%
Q4 revenue beat guidance; management expects continued momentum in 2026 with 20% growth in aerospace/defense.
Risks flagged
Industrial segment revenue decline and gross margin pressure from product mix shift.
“Industrial Solutions revenue decreased 21%...stronger than expected printer sales...weighed on gross margins”
9 Mar 202610-KRevenue $387M (-12% y/y); Operating cash flow $-88M; Cash and equivalents $96M (-44% y/y)open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $387M | -12% y/y |
| Operating cash flow · FY2025 | $-88M | |
| Cash and equivalents · 2025-12-31 | $96M | -44% y/y |
| Healthcare Solutions Revenue · Healthcare Solutions · FY2025 | $180M | -5% y/y |
| Industrial Solutions Revenue · Industrial Solutions · FY2025 | $207M | -17% y/y |
| Gross Profit Margin · FY2025 | 33.9% | |
| Healthcare Solutions Gross Profit · Healthcare Solutions · FY2025 | $72M | -2% y/y |
| Industrial Solutions Gross Profit · Industrial Solutions · FY2025 | $59M | -35% y/y |
| Product Revenue · FY2025 | $223M | -20% y/y |
| Service Revenue · FY2025 | $163M | +2% y/y |
Risks flagged
Material Weaknesses in Internal Controls
“management has concluded that the Company did not maintain effective internal control over financial reporting as of December 31, 2025, due to the following material weaknesses. We did not design and maintain adequate controls within the revenue process to address the determination of standalone selling price (“SSP”) and allocation of the transaction price t” · word for word
SEC Investigation
“the SEC, which has been conducting a formal investigation of the Company since April 2022 as a follow on to the previously disclosed SEC voluntary request for documents.” · word for word
Revenue Decline and Negative Operating Cash Flow
“Net cash used in operating activities $ (87,828) for the year ended December 31, 2025” · word for word
Debt Covenant Compliance Risk
“We are subject to a financial covenant under the 2030 Indenture requiring us to maintain at least $20.0 million in qualified cash.” · word for word
Export Control Violation Risk
“In February 2023, the Company settled these matters with all three agencies. In February 2026, DTCC approved the Company’s spend of the remaining suspended penalty balance, resulting in no further suspended penalty due.” · word for word
22 Dec 20258-K · 1.01Minimum cash requirement $20Mopen
Figures in the filing · each found in the filing text
| Minimum cash requirement · point_in_time | $20M |
Risks flagged
Reduced liquidity buffer may increase financial risk, but also provides flexibility.
“Reduction of minimum cash requirement from $40M to $20M.”
16 Dec 20258-K · 3.02, 8.01Shares issued for services 695,435; shares issued in debt exchange 16,625,243; remaining convertible notes principal $4Mshare dilutionopen
Figures in the filing · each found in the filing text
| shares issued for services · Q4-2025 | $695435.00 | |
| shares issued in debt exchange · Q4-2025 | $17M | |
| remaining convertible notes principal · Q4-2025 | $4M |
Risks flagged
Massive dilution: 17.3M shares issued with no cash proceeds; existing shareholders' ownership significantly reduced.
“issued 695,435 shares...exchanged $30,773,000 aggregate principal amount...for an aggregate of 16,625,243 shares”
9 Dec 20258-K · 1.01, 3.02, 8.01Aggregate principal amount of 2026 Notes exchanged $31M; Shares issued in exchange 16,625,243open
Figures in the filing · each found in the filing text
| Aggregate principal amount of 2026 Notes exchanged · Q4-2025 | $31M | |
| Shares issued in exchange · Q4-2025 | 16,625,243 |
Risks flagged
Severe dilution and liquidity risk
“16.6M shares issued for $30.8M debt; minimum cash covenant reduced from $40M to $20M”
4 Nov 202510-Q3D Systems reported a 19.2% year-over-year revenue decline in Q3 2025, with gross margin contracting 460 bps, reflecting ongoing macroeconomic headwinds.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $91M | -19% y/y |
| Healthcare Solutions Revenue · Healthcare Solutions · Q3-2025 | $43M | -22% y/y |
| Industrial Solutions Revenue · Industrial Solutions · Q3-2025 | $48M | -16% y/y |
| Gross Profit · Q3-2025 | $29M | -29% y/y |
| Net Income (Loss) Attributable to 3D Systems · Q3-2025 | $-18M | |
| Cash and Equivalents · Q3-2025 | $49M | |
| EPS Diluted · Q3-2025 | $-0.14 |
Risks flagged
Revenue concentration risk
“For the three months ended September 30, 2025, one customer accounted for 11.2 % of our consolidated revenue.” · word for word
Litigation risk (SEC investigation, securities class action, derivative actions)
“The Company is continuing to cooperate with the SEC in connection with its formal investigation.” · word for word
Goodwill impairment risk
“Although no impairment was identified during the interim test, future changes in operating results, cash flows, share price, market capitalization, or discount rates could adversely affect the implied fair value of goodwill and may result in future impairment charges.” · word for word
Debt covenant compliance risk
“The 2030 Indenture also includes certain financial covenants, including a requirement for the Note Parties to maintain certain minimum cash, accounts receivable and inventory balances each quarter.” · word for word
4 Nov 20258-K · 2.02Revenue $91M (-19% y/y); Gross profit $29M (-30% y/y); Gross profit margin 32.3; Guidance: Q4 sequential growth of 8-10% expected; gross margins and opex in line with current levelsearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $91M | -19% y/y |
| Gross profit · Q3-2025 | $29M | -30% y/y |
| Gross profit margin · Q3-2025 | 32.3% | |
| Operating expense · Q3-2025 | $51M | -77% y/y |
| Operating loss · Q3-2025 | $-21M | |
| Net loss attributable to 3D Systems Corporation · Q3-2025 | $-18M | |
| Diluted loss per share · Q3-2025 | $-0.14 | |
| Adjusted EBITDA · Q3-2025 | $-11M | |
| Healthcare Solutions revenue · Healthcare Solutions · Q3-2025 | $43M | -22% y/y |
| Industrial Solutions revenue · Industrial Solutions · Q3-2025 | $49M | -16% y/y |
Guidance
Q4 sequential growth of 8-10% expected; gross margins and opex in line with current levels
Q4 guidance for sequential growth but no full-year guidance; margins expected stable.
Risks flagged
Revenue decline and margin pressure from customer capex curtailment and divestiture.
“Total revenue decreased 19% to $91.2 million... Gross profit margin decreased to 32.3% from 36.9%” · word for word
Cash burn from operations ($73.1M YTD) and debt maturities in 2026 ($34.7M) and 2030 ($92.0M).
“Cash and cash equivalents decreased by $75.8 million since December 31, 2024... cash used in operations of $73.1 million” · word for word
Tariff headwinds from rising printer sales could pressure gross margins.
“tariff headwinds from rising printer sales” · word for word
3D Systems Corporation — questions
- What did 3D Systems Corporation file recently?
- 16 SEC filings in the last 12 months. Latest: 8-K on 2026-08-04 — Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)
Every figure on this page comes from 3D Systems Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.